Thu, Apr 17, 2014, 11:53 AM EDT - U.S. Markets close in 4 hrs 7 mins

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

  • scistats scistats Apr 23, 2013 5:53 PM Flag

    Looking forward: Z160 success and a Snutch Nobel Prize

    Dr. Snutch, simply Terry to the Zalicus faithful, pioneered cone snail toxin mechanism characterization in the mammalian nervous system. He has a legacy of articles many labeled as "Classics" by Science magazine. He really has the foundation for a Nobel Prize here, and Z160 could be a big part of this potential prestigious recognition.

    For the investor, a successful phase 2a would likely put ZLCS back on the NASDAQ at a PPS of around what? Anybody have any idea what the POTENTIAL of a pain medicine that can replace addictive opioids might demand at the phase 2a development stage? I am guessing what, 5 PPS?

    Of course failure is always an option, a real option, but there is no need to guess the PPS should this happen. Odds according to Jason Napodano are 20% probability of success while CFO Justin Renz says 50-50% according to Garrett.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ZLCS
1.24-0.11(-8.10%)11:53 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.